Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Alison Yarnall.

Newcastle AuthorsTitleYearFull text
Dr Calum Hamilton
Dr James Frith
Dr Paul Donaghy
Dr Rory Durcan
Dr Sarah Lawley
et al.
Assessment of autonomic symptoms may assist with early identification of mild cognitive impairment with Lewy bodies2022
Dr Calum Hamilton
Dr James Frith
Dr Paul Donaghy
Sally Barker
Dr Rory Durcan
et al.
Blood pressure and heart rate responses to orthostatic challenge and Valsalva manoeuvre in mild cognitive impairment with Lewy bodies2022
Dr Alison Yarnall
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches2022
Dr Rachel Cullinan
Dr Sarah Richardson
Dr Alison Yarnall
Professor David Burn
Dr Louise Allan
et al.
Documentation and Diagnosis of Delirium in Parkinson’s Disease2022
Dr Alison Yarnall
Emerging non-invasive therapeutic approaches targeting hypocholinergic neural systems in Parkinson’s disease2022
Dr Ríona McArdle
Dr Silvia Del Din
Dr Lisa Alcock
Dr Alison Yarnall
Professor David Burn
et al.
Factors Influencing Habitual Physical Activity in Parkinson’s Disease: Considering the Psychosocial State and Wellbeing of People with Parkinson’s and Their Carers2022
Dr Jake Gibbon
Dr Steve Parry
Professor Miles Witham
Dr Alison Yarnall
Dr James Frith
et al.
Feasibility, reliability and safety of self-assessed orthostatic blood pressure at home2022
Dr Rachael Lawson
Dr Hilmar Sigurdsson
Joanna Wilson
Dr Brook Galna
Dr Susan Lord
et al.
Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease2022
Dr Hilmar Sigurdsson
Dr Alison Yarnall
Dr Brook Galna
Dr Susan Lord
Dr Lisa Alcock
et al.
Gait-related metabolic covariance networks at rest in Parkinson’s disease2022
Dr Charalampos Tzoulis
Dr Gavin Hudson
Dr Rachael Lawson
Dr Alison Yarnall
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study2022
Dr Rana Rehman
Dr Yu Guan
Dr Jian Shi
Dr Lisa Alcock
Dr Alison Yarnall
et al.
Investigating the Impact of Environment and Data Aggregation by Walking Bout Duration on Parkinson’s Disease Classification Using Machine Learning2022
Dr Jenni Naisby
Dr Alison Yarnall
Professor Lynn Rochester
Professor Richard Walker
A Survey of People With Parkinson’s and Their Carers: The Management of Pain in Parkinson’s 2021
Dr Silvia Del Din
Cameron Kirk
Dr Alison Yarnall
Professor Lynn Rochester
Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead2021
Joanna Wilson
Dr Alison Yarnall
Dr Brook Galna
Dr Rachael Lawson
Dr Lisa Alcock
et al.
Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease2021
Dr Rachael Lawson
Dr Sarah Richardson
daisy Kershaw
Professor Bloss Stephan
Professor Carol Brayne
et al.
Evaluation of bedside tests of attention and arousal assessing delirium in Parkinson’s disease, dementia and older adults2021
Dr Silvia Del Din
Dr Alison Yarnall
Professor Lynn Rochester
Exenatide once weekly over 2 years as a potential disease modifying treatment for Parkinson's disease: protocol for a multi-centre, randomised, double blind, parallel group, placebo controlled, Phase 3 trial, The 'Exenatide-PD3' study2021
Dr Ríona McArdle
Dr Silvia Del Din
Dr Alison Yarnall
Gait analysis as a clinical tool for dementia: current perspectives and future challenges2021
Dr Hilmar Sigurdsson
Dr Rachael Raw
Heather Hunter
Dr Mark Baker
Professor John-Paul Taylor
et al.
Noninvasive vagus nerve stimulation in Parkinson’s disease: current status and future prospects2021
Dr Rana Rehman
Professor Lynn Rochester
Dr Alison Yarnall
Dr Silvia Del Din
Predicting the Progression of Parkinson’s Disease MDS-UPDRS-III Motor Severity Score from Gait Data using Deep Learning.2021
Sammy Waite
Stu Maitland
Professor Alan Thomas
Dr Alison Yarnall
Sarcopenia and frailty in individuals with dementia: A systematic review2021
Dr Sean Colloby
Dr Rachael Lawson
Dr Alison Yarnall
Professor David Burn
Professor John O'Brien
et al.
Spatial covariance of cholinergic muscarinic M1/M4 receptors in Parkinson’s disease2021
Dr Lisa Alcock
Dr Philip Brown
Dr Hugo Hiden
Cameron Kirk
Dr Encarna Mico Amigo
et al.
Technical validation of real-world monitoring of gait: a multicentric observational study2021
Dr Jenni Naisby
Dr Rachael Lawson
Dr Brook Galna
Dr Lisa Alcock
Professor David Burn
et al.
Trajectories of pain over six years in early Parkinson’s disease: ICICLE-PD2021
Cameron Kirk
Dr Encarna Mico Amigo
Magda Bosch de Basea Gomez
Dr Alison Yarnall
Professor Lynn Rochester
et al.
Walking on common ground: A cross-disciplinary scoping review on the clinical utility of digital mobility outcomes2021
Dr Rachael Lawson
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor Lynn Rochester
Professor David Burn
et al.
Which neuropsychological tests? Predicting cognitive decline and dementia in Parkinson’s disease in the ICICLE-PD cohort2021
Dr Silvia Del Din
Dr Alison Yarnall
Professor Lynn Rochester
Continuous Real-World Gait Monitoring in Idiopathic REM Sleep Behavior Disorder2020
Joanna Wilson
Dr Lisa Alcock
Dr Alison Yarnall
Dr Susan Lord
Dr Rachael Lawson
et al.
Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology2020
Dr Rachael Lawson
Dr Sarah Richardson
Dr Alison Yarnall
Professor David Burn
Dr Louise Allan
et al.
Identifying delirium in Parkinson’s disease: a pilot study2020
Dr Rory Durcan
Dr Paul Donaghy
Nicola Barnett
Kirsty Olsen
Dr Alison Yarnall
et al.
Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodies2020
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor David Burn
Dr Rachael Lawson
Dr Alison Yarnall
et al.
Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD)2020
Dr Carmen Martin-Ruiz
Dr Alison Yarnall
Dr John Boucher
Dr Rachael Lawson
Claire Kolenda
et al.
Senescence and inflammatory markers for predicting clinical progression in Parkinson's disease-the ICICLE-PD study2020
Dr Alison Yarnall
Dr Antoneta Granic
Sammy Waite
Dr Kieren Hollingsworth
Charlotte Warren
et al.
The feasibility of muscle mitochondrial respiratory chain phenotyping across the cognitive spectrum in Parkinson’s disease2020
Dr Hannah Lowes
Dr Fiona Robertson
Dr Angela Pyle
Raf Hussain
Dr Jonathan Coxhead
et al.
The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's Disease2020
Dr Zhe Kang Law
Carein Todd
Ramtin Mehraram
Julia Schumacher
Dr Mark Baker
et al.
The role of EEG in the diagnosis, prognosis and clinical correlations of Dementia with Lewy Bodies—a systematic review2020
Dr Rachael Lawson
Dr Alison Yarnall
Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson’s disease2020
Sebastian Koch
Dr Alison Yarnall
Professor Lynn Rochester
Walking-related digital mobility outcomes as clinical trial endpoint measures: Protocol for a scoping review2020
Dr Rana Rehman
Dr Silvia Del Din
Dr Jian Shi
Dr Brook Galna
Dr Alison Yarnall
et al.
Comparison of walking protocols and gait assessment systems for machine learning based classification of Parkinson’s disease2019
Professor John O'Brien
Dr Paul Donaghy
Dr Rachael Lawson
Dr Christopher Morris
Nicola Barnett
et al.
Inflammation in Mild Cognitive Impairment due to Parkinson’s disease, Lewy Body disease and Alzheimer’s disease2019
Dr Rosie Morris
Dr Alison Yarnall
Heather Hunter
Professor John-Paul Taylor
Dr Mark Baker
et al.
Noninvasive vagus nerve stimulation to target gait impairment in Parkinson's disease2019
Dr Rory Durcan
Dr Lou Wiblin
Dr Rachael Lawson
Dr Tien Kheng Khoo
Dr Alison Yarnall
et al.
Prevalence and duration of non‐motor symptoms in prodromal Parkinson's disease2019
Dr Sam Stuart
Dr Rachael Lawson
Dr Alison Yarnall
Dr Lisa Alcock
Dr Tien Kheng Khoo
et al.
Pro‐Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE‐PD 2019
Dr Rana Rehman
Dr Silvia Del Din
Dr Yu Guan
Dr Alison Yarnall
Dr Jian Shi
et al.
Selecting Clinically Relevant Gait Characteristics for Classification of Early Parkinson’s Disease: A Comprehensive Machine Learning Approach2019
Dr Christopher Buckley
Dr Lisa Alcock
Dr Ríona McArdle
Dr Rana Rehman
Dr Silvia Del Din
et al.
The role of movement analysis in diagnosing and monitoring neurodegenerative conditions: Insights from gait and postural control2019
Dr Isobel Sleeman
Dr Rachael Lawson
Dr Alison Yarnall
Dr Gordon Duncan
Dr Fionnuala Johnston
et al.
Urate and homocysteine: predicting motor and cognitive changes in newly diagnosed Parkinson’s disease2019
Benjamin Clegg
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor David Burn
Dr Alison Yarnall
et al.
Categorising visual hallucinations in early Parkinson's disease2018
Dr Michael Firbank
Dr Rachael Lawson
Dr Alison Yarnall
Professor David Brooks
Professor David Burn
et al.
Longitudinal diffusion tensor imaging changes in early Parkinson’s disease: ICICLE-PD study2018
Dr Rhys Gravell
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor David Burn
Professor Avan Sayer
et al.
Multimorbidity predicts quality of life but not motor severity in early Parkinson's disease2018
Dr Annette Pantall
Dr Alison Yarnall
Dr Silvia Del Din
Professor Lynn Rochester
Postural dynamics are associated with cognitive decline in Parkinson's disease2018
Dr Alison Yarnall
Professor Lynn Rochester
Dr Susan Lord
A novel approach to falls classification in Parkinson’s disease: Development of the Fall-Related Activity Classification (FRAC)2017
Dr Rachael Lawson
Dr Alison Yarnall
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor David Burn
et al.
Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson’s disease2017
Dr Michael Firbank
Dr Alison Yarnall
Dr Rachael Lawson
Dr Gordon Duncan
Dr Tien Kheng Khoo
et al.
Cerebral glucose metabolism and cognition in newly diagnosed Parkinson’s disease: ICICLE-PD study2017
Dr Rachael Lawson
Dr Alison Yarnall
Dr Fionnuala Johnston
Dr Gordon Duncan
Dr Tien Khoo
et al.
Cognitive impairment in Parkinson's disease: impact on quality of life carers2017
Professor Lynn Rochester
Dr Brook Galna
Dr Susan Lord
Dr Alison Yarnall
Dr Rosie Morris
et al.
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson’s disease2017
Dr Rosie Morris
Dr Susan Lord
Dr Rachael Lawson
Dr Shirley Coleman
Dr Brook Galna
et al.
Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson’s Disease2017
Dr Susan Lord
Dr Brook Galna
Dr Alison Yarnall
Dr Shirley Coleman
Professor David Burn
et al.
Have we been overestimating fall rates in Parkinson's disease?2017
Dr Luis Peraza Rodriguez
Dr Rachael Lawson
Dr Gordon Duncan
Dr Alison Yarnall
Dr Michael Firbank
et al.
Intra- and inter-network functional alterations in Parkinson's disease with mild cognitive impairment2017
Dr Michael Firbank
Dr Rachael Lawson
Dr Alison Yarnall
Dr Gordon Duncan
Dr Tien Kheng Khoo
et al.
Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease2017
Dr Florence Burte
Dr Dave Houghton
Hannah Lowes
Dr Angela Pyle
Sarah Nesbitt
et al.
Metabolic profiling of Parkinson's disease and mild cognitive impairment2017
Dr Susan Lord
Dr Brook Galna
Dr Alison Yarnall
Dr Rosie Morris
Dr Shirley Coleman
et al.
Natural history of falls in an incident cohort of Parkinson’s disease: early evolution, risk and protective features2017
Dr Alison Yarnall
Professor Avan Sayer
Professor Stuart Parker
New Horizons in Multimorbidity in Older Adults2017
Dr Sean O'Dowd
Dr Brook Galna
Dr Rosie Morris
Dr Rachael Lawson
Dr Claire McDonald
et al.
Poor Sleep Quality and Progression of Gait Impairment in an Incident Parkinson’s Disease Cohort2017
Dr Sam Stuart
Dr Lisa Alcock
Dr Jez Nell
Dr Rachael Lawson
Dr Rosie Morris
et al.
Pro-saccades predict decline in attention over 18 months in newly diagnosed Parkinson’s disease2017
Dr Rachael Lawson
Dr Alison Yarnall
Dr Gordon Duncan
Dr Tien Khoo
Professor David Burn
et al.
Stability of mild cognitive impairment in newly diagnosed Parkinson’s disease2017
Dr Isobel Sleeman
Dr Terry Aspray
Dr Rachael Lawson
Professor David Burn
Dr Alison Yarnall
et al.
The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease2017
Dr Alison Yarnall
Dr Shirley Coleman
Professor David Burn
Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?2016
Dr Rachael Lawson
Dr Alison Yarnall
Dr Gordon Duncan
Dr Tien Kheng Khoo
Daniel Collerton
et al.
Cognitive decline and quality of life in incident Parkinson’s disease: the role of attention2016
Dr Gordon Duncan
Dr Michael Firbank
Dr Alison Yarnall
Dr Tien Kheng Khoo
Professor David Brooks
et al.
Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?2016
Dr Susan Lord
Dr Brook Galna
Dr Alison Yarnall
Dr Shirley Coleman
Professor David Burn
et al.
Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall-naïve cohort2016
Dr Luis Peraza Rodriguez
Dr Rachael Lawson
Dr Michael Firbank
Dr Alison Yarnall
Professor David Brooks
et al.
Principal component discriminant analysis of mild cognitive impairment in Parkinson’s disease reveals early functional changes in the resting state2016
Dr Angela Pyle
Haidyan Anugrha
Dr Marzena Kurzawa-Akanbi
Dr Alison Yarnall
Professor David Burn
et al.
Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease2016
Dr Angela Pyle
Hannah Lowes
Rebecca Brennan
Dr Marzena Kurzawa-Akanbi
Dr Alison Yarnall
et al.
Reduced Mitochondrial DNA Is Not a Biomarker of Depression in Parkinson's Disease2016
Dr Alison Yarnall
Dr Rachael Lawson
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor David Burn
et al.
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)2016
Dr Alison Yarnall
Professor Lynn Rochester
Professor David Burn
Dr Mark Baker
Short latency afferent inhibition: Effects of ageing2016
Dr Claire McDonald
Dr Rachael Lawson
Dr Gordon Duncan
Dr Sean O'Dowd
Dr Alison Yarnall
et al.
The Frequency and Progression of Genitourinary and Gastrointestinal Symptoms in Parkinson’s disease and Healthy Controls Over 36 months Follow-up in the ICICLE-PD Study2016
Dr Alison Yarnall
Dr Rachael Lawson
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor David Brooks
et al.
Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?2015
Dr Michael Firbank
Dr Rachael Lawson
Dr Alison Yarnall
Dr Tien Kheng Khoo
Professor David Brooks
et al.
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study2015
Dr Rachael Lawson
Dr Alison Yarnall
Dr Tien Kheng Khoo
Professor David Brooks
Professor David Burn
et al.
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study2015
Dr Alison Yarnall
Professor David Deehan
Occurrence, management and outcomes of hip fractures in patients with Parkinson's disease2015
Dr Angela Pyle
Rebecca Brennan
Dr Marzena Kurzawa-Akanbi
Dr Alison Yarnall
Anais Thouin
et al.
Reduced CSF mitochondrial DNA is a biomarker for early-stage Parkinson's disease2015
Dr Emma Vardy
Dr Andrew Teodorczuk
Dr Alison Yarnall
Review of delirium in patients with Parkinson's disease2015
Dr Jennifer Duff
Dr Alison Yarnall
Professor David Burn
Dr Gavin Hudson
Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson's disease2015
Dr Alison Yarnall
Dr Gordon Duncan
Dr Shirley Coleman
Dr Michael Firbank
Dr Gavin Hudson
et al.
Characterizing mild cognitive impairment in incident Parkinson disease The ICICLE-PD Study2014
Dr Susan Lord
Dr Brook Galna
Dr Shirley Coleman
Dr Alison Yarnall
Professor David Burn
et al.
Cognition and gait show a selective pattern of association dominated by phenotype in incident Parkinson's disease2014
Professor Lynn Rochester
Dr Susan Lord
Dr Alison Yarnall
Professor David Burn
Falls in patients with dementia2014
Dr David Nesbitt
Dr Luis Peraza Rodriguez
Dr Rachael Lawson
Dr Alison Yarnall
Dr Michael Firbank
et al.
fMRI resting state connectivity in Parkinson's with mild cognitive impairment2014
Dr Gordon Duncan
Dr Tien Khoo
Dr Alison Yarnall
Dr Michael Firbank
Professor Patrick Chinnery
et al.
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study2014
Dr Gordon Duncan
Dr Tien Kheng Khoo
Dr Alison Yarnall
Professor John O'Brien
Dr Shirley Coleman
et al.
Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms2014
Professor David Burn
Dr Alison Yarnall
Motor symptoms and phenotype in patients with Parkinson’s disease dementia2014
Dr Alison Yarnall
Dr Silvia Del Din
Dr Brook Galna
Dr Mark Baker
Professor David Burn
et al.
Postural control stabilises over the first 30 seconds of quiet standing in Parkinson’s disease: time series analysis2014
Dr Ben Prudon
Dr Gordon Duncan
Dr Tien Kheng Khoo
Dr Alison Yarnall
Professor David Burn
et al.
Primary sleep disorder prevalence in patients with newly diagnosed Parkinson's Disease2014
Dr Rachael Lawson
Dr Alison Yarnall
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor John-Paul Taylor
et al.
Quality of Life and Mild Cognitive Impairment in Early Parkinson's Disease: Does Subtype Matter?2014
Dr Rachael Lawson
Dr Alison Yarnall
Dr Gordon Duncan
Dr Tien Kheng Khoo
Daniel Collerton
et al.
Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life2014
Dr Gordon Duncan
Dr Tien Kheng Khoo
Dr Shirley Coleman
Professor Carol Brayne
Dr Alison Yarnall
et al.
The Incidence of Parkinson's Disease in the North East of England2014
Dr Alison Yarnall
What are the priorities in Parkinson’s disease clinical research? A focus on motor complications, gait and cognition2014
Dr Alison Yarnall
Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes2013
Professor David Burn
Dr Alison Yarnall
Dementia in Parkinson’s Disease2013
Dr Gordon Duncan
Dr Alison Yarnall
Dr Michael Firbank
Professor John O'Brien
Professor David Burn
et al.
Grey matter and CSF amyloid in early non-demented Parkinson's disease: the incidence of cognitive impairment in cohorts with longitudinal evaluation - Parkinson's disease (ICICLE-PD) study2013
Dr Gordon Duncan
Dr Michael Firbank
Dr Alison Yarnall
Professor John O'Brien
Professor David Burn
et al.
Grey matter correlations of cognitive impairment in early Parkinson's disease: the incidence of cognitive impairment in cohorts with longitudinal evaluation - Parkinson's disease (ICICLE-PD) study2013
Dr Gordon Duncan
Dr Michael Firbank
Dr Alison Yarnall
Professor David Burn
Grey matter correlations of cognitive impairment in early Parkinson's disease: the incidence of cognitive impairment in cohorts with longitudinal evaluation - Parkinson's disease (ICICLE-PD) study2013
Dr Gordon Duncan
Dr Michael Firbank
Dr Alison Yarnall
Dr Tien Khoo
Professor John O'Brien
et al.
Grey Matter Correlations of Cognitive Impairment in Early Parkinson's Disease: The Incidence of Cognitive Impairment In Cohorts with Longitudinal Evaluation: Parkinson's Disease (ICICLE-PD) Study2013
Dr Gordon Duncan
Dr Michael Firbank
Dr Alison Yarnall
Professor John O'Brien
Professor David Burn
et al.
Grey Matter Correlations of Cognitive Impairment in Early Parkinson's Disease: The Incidence of Cognitive Impairment in Cohorts with Longitudinal Evaluation-Parkinson's Disease (ICICLE-PD) Study2013
Dr Alison Yarnall
Professor Lynn Rochester
Professor David Burn
Mild cognitive impairment in Parkinson's disease2013
Dr Gordon Duncan
Dr Alison Yarnall
Dr Sarah Marrinan
Professor David Burn
New horizons in the pathogenesis, assessment and management of movement disorders2013
Dr Ben Prudon
Dr Gordon Duncan
Dr Alison Yarnall
Professor David Burn
Dr Kirstie Anderson
et al.
Primary sleep disorder prevalence in patients with newly diagnosed Parkinson's disease2013
Dr Andrew Ford
Dr Gordon Duncan
Dr Michael Firbank
Dr Alison Yarnall
Dr Tien Khoo
et al.
Rapid eye movement sleep behavior disorder in Parkinson's disease: Magnetic resonance imaging study2013
Dr Alison Yarnall
Professor Lynn Rochester
Dr Mark Baker
Dr Tien Khoo
Dr Gordon Duncan
et al.
Short latency afferent inhibition: A biomarker for mild cognitive impairment in Parkinson's disease?2013
Dr John Boucher
Dr Gordon Duncan
Dr Alison Yarnall
Professor John O'Brien
Professor Thomas von Zglinicki
et al.
Telomere length and cognitive impairment in early Parkinson's disease2013
Dr Gordon Duncan
Dr Tien Khoo
Dr Alison Yarnall
Professor John O'Brien
Professor David Burn
et al.
The impact of motor and non-motor symptoms upon health-related quality of life in early Parkinson's disease: the incidence of cognitive impairment in cohorts with longitudinal evaluation: Parkinson's Disease (ICICLE-PD) Study2013
Dr Tien Khoo
Dr Alison Yarnall
Dr Gordon Duncan
Dr Shirley Coleman
Professor John O'Brien
et al.
The spectrum of nonmotor symptoms in early Parkinson disease2013
Emeritus Professor Roger Francis
Professor Elaine McColl
Dr Thomas Chadwick
Christine Harle
Dr Alison Yarnall
et al.
Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D32013
Dr Alison Yarnall
Professor David Burn
Amantadine-induced myoclonus in a patient with progressive supranuclear palsy2012
Dr Alison Yarnall
Dr Tien Khoo
Dr Gordon Duncan
Professor David Brooks
Professor David Burn
et al.
Anti-cholinergic load: Is there a cognitive cost in early Parkinson’s disease?2012
Dr Tien Kheng Khoo
Dr Gordon Duncan
Dr Alison Yarnall
Professor David Brooks
Professor John O'Brien
et al.
Apathy in incident Parkinson’s disease2012
Professor Lynn Rochester
Dr Alison Yarnall
Dr Susan Lord
Dr Brook Galna
Professor David Burn
et al.
Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease2012
Dr Alison Yarnall
Professor Lynn Rochester
Dr Gordon Duncan
Dr Tien Kheng Khoo
Professor David Brooks
et al.
Cholinergic dysfunction in Parkinson’s disease with mild cognitive impairment: a short latency afferent inhibition study2012
Dr Tien Kheng Khoo
Dr Gordon Duncan
Dr Alison Yarnall
Professor John O'Brien
Professor David Burn
et al.
Depression and anxiety in incident Parkinson’s disease2012
Dr Alison Yarnall
Dr Louise Hayes
Dr Gillian Hawthorne
Dr Terry Aspray
Diabetes in care homes: current care standards and residents' experience2012
Dr Gordon Duncan
Dr Tien Kheng Khoo
Dr Alison Yarnall
Professor John O'Brien
Professor David Brooks
et al.
Elevated homocysteine levels and cognitive dysfunction in an incident cohort of non-demented Parkinson’s disease patients.2012
Dr Alison Yarnall
Dr Gordon Duncan
Professor David Burn
Falling short: Underestimation of fracture risk in atypical parkinsonian syndromes2012
Dr Tien Kheng Khoo
Dr Michael Firbank
Dr Alison Yarnall
Dr Gordon Duncan
Professor John O'Brien
et al.
Inefficiency of fronto-parietal networks in incident Parkinson’s disease2012
Dr Tien Kheng Khoo
Dr Michael Firbank
Dr Alison Yarnall
Dr Gordon Duncan
Professor John O'Brien
et al.
Spatial planning ability in early stage Parkinson’s disease patients (ICICLE-PD)2012
Dr Tien Kheng Khoo
Dr Gordon Duncan
Dr Alison Yarnall
Professor John O'Brien
Professor David Burn
et al.
The incidence of Parkinson’s disease in North East England2012
Dr Alison Yarnall
Dr Louise Hayes
Dr Gillian Hawthorne
Charlotte Candlish
Dr Terry Aspray
et al.
Diabetes in care homes: Residents' experience of care2011
Dr Alison Yarnall
Low CSF alpha-Synuclein Levels May Facilitate the Prediction of Synucleinopathies2011
Dr Alison Yarnall
Professor Lynn Rochester
Professor David Burn
The interplay of cholinergic function, attention, and falls in Parkinson's disease2011
Dr Alison Yarnall
Dr Gillian Hawthorne
Recent clinical trials in diabetes- implications for managing older patients2009
Dr Alison Yarnall
Dr Deborah Mayne
Dr Terry Aspray
Diabetes and the older person2008
Dr Fiona Hampton
Dr Alison Yarnall
Dr David Spencer
Tolerance of spacers with masks is frequently poor in young children2001